Cardiovascular disease remains the major cause of mortality, and cardiac cell therapy has recently emerged as a paradigm for heart repair. The epicardium is a layer of mesothelial cells covering the heart that during development contributes to different cardiovascular lineages, including cardiomyocytes, but which becomes quiescent after birth. We previously revealed that the peptide thymosin beta 4 (Tβ4) can reactivate adult epicardium-derived cells (EPDCs) after myocardial infarction (MI), to proliferate, and differentiate into cardiovascular derivatives. The aim of this study was to provide a lineage characterization of the adult EPDCs relative to the embryonic epicardial lineage and to determine prospective cell fate biases within the activated adult population during cardiovascular repair. Wt1GFPCre/+ mice were primed with Tβ4 and MI induced by ligation of the left anterior descending coronary artery. Adult WT1+ GFP+ EPDCs were fluorescence-activated cell sorted (FACS) at 2, 4, and 7 days after MI. Embryonic WT1+ GFP+ EPDCs were isolated from embryonic hearts (E12.5) by FACS, and sorted cells were characterized by real-time quantitative reverse transcriptase–polymerase chain reaction (RT-qPCR) and immunostaining. Adult WT1+ GFP+ EPDCs were highly heterogeneous, expressing cardiac progenitor and mesenchymal stem markers. Based on the expression of stem cell antigen-1 (Sca-1), CD44, and CD90, we identified different subpopulations of EPDCs of varying cardiovascular potential, according to marker gene profiles, with a molecular phenotype distinct from the source embryonic epicardial cells at E12.5. Thus, adult WT1+ GFP+ cells are a heterogeneous population that when activated can restore an embryonic gene programme, but do not revert entirely to adopt an embryonic phenotype. Potential biases in cardiovascular cell fate suggest that discrete subpopulations of EPDCs might be clinically relevant for regenerative therapy.
Get full access to this article
View all access options for this article.
References
1.
GoAS, MozaffarianD, RogerVL, BenjaminEJ, BerryJD, BordenWB, BravataDM, DaiS, FordES, et al. (2013). Heart disease and stroke statistics: 2013 Update. A report from the American Heart Association. Circulation, 127:e6–e245.
2.
BraunwaldE. (2013). Heart failure: an update. Clin Pharmacol Ther, 94:430–432.
3.
HuntSA. (2006). Taking heart—cardiac transplantation past, present, and future. N Engl J Med, 355:231–235.
4.
HuntSA and HaddadF. (2008). The changing face of heart transplantation. J Am Coll Cardiol, 52:587–598.
5.
FuhE and BrintonTJ. (2009). Bone marrow stem cells for the treatment of ischemic heart disease: a clinical trial review. J Cardiovasc Transl Res, 2:202–218.
6.
PennMS, MendelsohnFO, SchaerGL, ShermanW, FarrM, PastoreJ, RouyD, ClemensR, ArasR and LosordoDW. (2013). An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure. Circ Res, 112:816–825.
7.
SuncionVY, SchulmanIH and HareJM. (2012). Concise review: the role of clinical trials in deciphering mechanisms of action of cardiac cell-based therapy. Stem Cells Transl Med, 1:29–35.
8.
KangHJ, KimHS, ZhangSY, ParkKW, ChoHJ, KooBK, KimYJ, Soo LeeD, SohnDW, et al. (2004). Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet, 363:751–756.
9.
GnecchiM, ZhangZ, NiA and DzauVJ. (2008). Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res, 103:1204–1219.
10.
MaltaisS, TremblayJP, PerraultLP and LyHQ. (2010). The paracrine effect: pivotal mechanism in cell-based cardiac repair. J Cardiovasc Transl Res, 3:652–662.
11.
MirotsouM, JayawardenaTM, SchmeckpeperJ, GnecchiM and DzauVJ. (2011). Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J Mol Cell Cardiol, 50:280–289.
12.
NakanishiC, YamagishiM, YamaharaK, HaginoI, MoriH, SawaY, YagiharaT, KitamuraS and NagayaN. (2008). Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells. Biochem Biophys Res Commun, 374:11–16.
13.
LoffredoFS, SteinhauserML, GannonJ and LeeRT. (2011). Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell, 8:389–398.
14.
BolliniS, CheungKK, RieglerJ, DongX, SmartN, GhionzoliM, LoukogeorgakisSP, MaghsoudlouP, DubeKN, et al. (2011). Amniotic fluid stem cells are cardioprotective following acute myocardial infarction. Stem Cells Dev, 20:1985–1994.
15.
BeltramiAP, BarlucchiL, TorellaD, BakerM, LimanaF, ChimentiS, KasaharaH, RotaM, MussoE, et al. (2003). Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell, 114:763–776.
16.
MessinaE, DeAL, FratiG, MorroneS, ChimentiS, FiordalisoF, SalioM, BattagliaM, LatronicoMV, et al. (2004). Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res, 95:911–921.
ChenT, ChangTC, KangJO, ChoudharyB, MakitaT, TranCM, BurchJB, EidH and SucovHM. (2002). Epicardial induction of fetal cardiomyocyte proliferation via a retinoic acid-inducible trophic factor. Dev Biol, 250:198–207.
21.
ZhouB, von GiseA, MaQ, Rivera-FelicianoJ and PuWT. (2008). Nkx2-5- and Isl1-expressing cardiac progenitors contribute to proepicardium. Biochem Biophys Res Commun, 375:450–453.
22.
TomanekRJ. (2005). Formation of the coronary vasculature during development. Angiogenesis, 8:273–284.
23.
Red-HorseK, UenoH, WeissmanIL and KrasnowMA. (2010). Coronary arteries form by developmental reprogramming of venous cells. Nature, 464:549–553.
24.
ZhouB, MaQ, RajagopalS, WuSM, DomianI, Rivera-FelicianoJ, JiangD, vonGA, IkedaS, ChienKR and PuWT. (2008). Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature, 454:109–113.
25.
CaiCL, MartinJC, SunY, CuiL, WangL, OuyangK, YangL, BuL, LiangX, et al. (2008). A myocardial lineage derives from Tbx18 epicardial cells. Nature, 454:104–108.
26.
ChristoffelsVM, GrieskampT, NordenJ, MommersteegMT, RudatC and KispertA. (2009). Tbx18 and the fate of epicardial progenitors. Nature, 458:E8–E9; discussion E9–E10.
27.
SmartN, RisebroCA, MelvilleAA, MosesK, SchwartzRJ, ChienKR and RileyPR. (2007). Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. Nature, 445:177–182.
28.
SmartN, RisebroCA, ClarkJE, EhlerE, MiquerolL, RossdeutschA, MarberMS and RileyPR. (2010). Thymosin beta4 facilitates epicardial neovascularization of the injured adult heart. Ann N Y Acad Sci, 1194:97–104.
29.
SmartN, BolliniS, DubeKN, VieiraJM, ZhouB, DavidsonS, YellonD, RieglerJ, PriceAN, et al. (2011). De novo cardiomyocytes from within the activated adult heart after injury. Nature, 474:640–644.
30.
ZhouB and PuWT. (2012). Isolation and characterization of embryonic and adult epicardium and epicardium-derived cells. Methods Mol Biol, 843:155–168.
31.
MartinCM, MeesonAP, RobertsonSM, HawkeTJ, RichardsonJA, BatesS, GoetschSC, GallardoTD and GarryDJ. (2004). Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev Biol, 265:262–275.
32.
DominiciM, Le BlancK, MuellerI, Slaper-CortenbachI, MariniF, KrauseD, DeansR, KeatingA, ProckopD and HorwitzE. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8:315–317.
33.
Le BlancK, TammikL, SundbergB, HaynesworthSE and RingdenO. (2003). Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol, 57:11–20.
34.
ZhuH, MitsuhashiN, KleinA, BarskyLW, WeinbergK, BarrML, DemetriouA and WuGD. (2006). The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix. Stem Cells, 24:928–935.
35.
SacksteinR, MerzabanJS, CainDW, DagiaNM, SpencerJA, LinCP and WohlgemuthR. (2008). Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med, 14:181–187.
36.
AbbottJD, HuangY, LiuD, HickeyR, KrauseDS and GiordanoFJ. (2004). Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation, 110:3300–3305.
37.
DavisDR, ZhangY, SmithRR, ChengK, TerrovitisJ, MalliarasK, LiTS, WhiteA, MakkarR and MarbanE. (2009). Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue. PLoS One, 4:e7195
38.
ChongJJ, ChandrakanthanV, XaymardanM, AsliNS, LiJ, AhmedI, HeffernanC, MenonMK, ScarlettCJ, et al.Adult cardiac-resident MSC-like stem cells with a proepicardial origin. Cell Stem Cell, 9:527–540.
39.
MellgrenAM, SmithCL, OlsenGS, EskiocakB, ZhouB, KaziMN, RuizFR, PuWT and TallquistMD. (2008). Platelet-derived growth factor receptor beta signaling is required for efficient epicardial cell migration and development of two distinct coronary vascular smooth muscle cell populations. Circ Res, 103:1393–1401.
40.
SmartN, RisebroCA, MelvilleAA, MosesK, SchwartzRJ, ChienKR and RileyPR. (2007). Thymosin beta-4 is essential for coronary vessel development and promotes neovascularization via adult epicardium. Ann N Y Acad Sci, 1112:171–188.
41.
MorettiA, CaronL, NakanoA, LamJT, BernshausenA, ChenY, QyangY, BuL, SasakiM, et al. (2006). Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell, 127:1151–1165.
42.
BuL, JiangX, Martin-PuigS, CaronL, ZhuS, ShaoY, RobertsDJ, HuangPL, DomianIJ and ChienKR. (2009). Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature, 460:113–117.
43.
KattmanSJ, HuberTL and KellerGM. (2006). Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell, 11:723–732.
44.
Martin-PuigS, WangZ and ChienKR. (2008). Lives of a heart cell: tracing the origins of cardiac progenitors. Cell Stem Cell, 2:320–331.
45.
DurocherD, CharronF, WarrenR, SchwartzRJ and NemerM. (1997). The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors. EMBO J, 16:5687–5696.
46.
LimanaF, ZacheoA, MociniD, MangoniA, BorsellinoG, DiamantiniA, DeMR, BattistiniL, VignaE, et al. (2007). Identification of myocardial and vascular precursor cells in human and mouse epicardium. Circ Res, 101:1255–1265.
47.
Bock-MarquetteI, SaxenaA, WhiteMD, DiMaioJM and SrivastavaD. (2004). Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature, 432:466–472.
48.
LimanaF, BertolamiC, MangoniA, DiCA, AvitabileD, MociniD, IannelliP, DeMR, MarchettiC, et al. (2010). Myocardial infarction induces embryonic reprogramming of epicardial c-kit(+) cells: role of the pericardial fluid. J Mol Cell Cardiol, 48:609–618.
49.
KatzTC, SinghMK, DegenhardtK, Rivera-FelicianoJ, JohnsonRL, EpsteinJA and TabinCJ. (2012). Distinct compartments of the proepicardial organ give rise to coronary vascular endothelial cells. Dev Cell, 22:639–650.
IedaM, TsuchihashiT, IveyKN, RossRS, HongTT, ShawRM and SrivastavaD. (2009). Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling. Dev Cell, 16:233–244.
56.
DimmelerS and LeriA. (2008). Aging and disease as modifiers of efficacy of cell therapy. Circ Res, 102:1319–1330.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
